BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Black S, Bloom DE, Kaslow DC, Pecetta S, Rappuoli R. Transforming vaccine development. Semin Immunol 2020;50:101413. [PMID: 33127296 DOI: 10.1016/j.smim.2020.101413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nomura Y, Noda K, Oohashi Y, Okuda S, Matsumoto J, Nakano T, Tsuchida N, Ishii KJ, Hayashi K, Iiyama T, Onodera H, Ishii K, Shikano M, Okabe N. Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan. Vaccine 2022:S0264-410X(22)01144-6. [PMID: 36167693 DOI: 10.1016/j.vaccine.2022.09.036] [Reference Citation Analysis]
2 Sharma A, Apte A, Rajappa M, Vaz M, Vaswani V, Goenka S, Malhotra S, Sangoram R, Lakshminarayanan S, Jayaram S, Mathaiyan J, Farseena K, Mukerjee P, Jaswal S, Dongre A, Timms O, Shafiq N, Aggarwal R, Kaur M, Juvekar S, Sekhar A, Kang G. Perceptions about controlled human infection model (CHIM) studies among members of ethics committees of Indian medical institutions: A qualitative exploration. Wellcome Open Res 2022;7:209. [DOI: 10.12688/wellcomeopenres.17968.1] [Reference Citation Analysis]
3 Pecetta S, Tortorice D, Scorza FB, Pizza M, Dougan G, Hatchett R, Black S, Bloom DE, Rappuoli R. The trillion dollar vaccine gap. Sci Transl Med 2022;14:eabn4342. [PMID: 35353544 DOI: 10.1126/scitranslmed.abn4342] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Das SK, Paul M, Behera BC, Thatoi H. Current status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women. Expert Rev Vaccines 2022. [PMID: 35313785 DOI: 10.1080/14760584.2022.2056025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cabiedes-Miragaya L, Galende-Domínguez I. COVID-19 vaccines: a look at the ethics of the clinical research involving children. J Med Ethics 2022:medethics-2021-107941. [PMID: 35144979 DOI: 10.1136/medethics-2021-107941] [Reference Citation Analysis]
6 Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil L. A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure. Biologicals 2022. [DOI: 10.1016/j.biologicals.2022.02.003] [Reference Citation Analysis]
7 Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-salter T, Schmidt A, Semete-makokotlela B, Voss G, White RG, Zignol M, Giersing B. Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case. Vaccine 2022. [DOI: 10.1016/j.vaccine.2021.10.062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vickers CE, Freemont PS. Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time. Nat Commun 2022;13:453. [PMID: 35064129 DOI: 10.1038/s41467-022-28103-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Stefanetti G, Borriello F, Richichi B, Zanoni I, Lay L. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases. Front Cell Infect Microbiol 2022;11:808005. [DOI: 10.3389/fcimb.2021.808005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pizza M, Pecetta S, Rappuoli R. Vaccines 2020: The era of the digital vaccine is here. Sci Transl Med 2021;13:eabm3249. [PMID: 34910549 DOI: 10.1126/scitranslmed.abm3249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI. Innovations and development of Covid-19 vaccines: A patent review. J Infect Public Health 2021:S1876-0341(21)00342-7. [PMID: 34742639 DOI: 10.1016/j.jiph.2021.10.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
12 Schee Genannt Halfmann S, Evangelatos N, Kweyu E, van der Merwe A, Steinhausen K, Brand A. Best Practice Guidance for Creation and Management of Innovations in Health care and Information and Communications Technologies. OMICS 2021. [PMID: 34495756 DOI: 10.1089/omi.2021.0043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Pascual-Iglesias A, Canton J, Ortega-Prieto AM, Jimenez-Guardeño JM, Regla-Nava JA. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era. Pathogens 2021;10:1030. [PMID: 34451494 DOI: 10.3390/pathogens10081030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
14 Huang D, Liu AYN, Leung KS, Tang NLS. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion. Genes (Basel) 2021;12:971. [PMID: 34202032 DOI: 10.3390/genes12070971] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Singh N, Villoutreix BO. Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises. Comput Struct Biotechnol J 2021;19:2537-48. [PMID: 33936562 DOI: 10.1016/j.csbj.2021.04.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bonelli F, Blocki FA, Bunnell T, Chu E, De La O A, Grenache DG, Marzucchi G, Montomoli E, Okoye L, Pallavicini L, Streva VA, Torelli A, Wagner A, Zanin D, Zierold C, Wassenberg JJ. Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies. Clin Chem Lab Med 2021;59:1463-7. [PMID: 33711225 DOI: 10.1515/cclm-2021-0023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
17 Serbezova A, Mangelov M, Zaykova K, Nikolova S, Zhelyazkova D, Balgarinova N. Knowledge and attitude toward COVID-19 vaccines amongst medical, dental and pharmacy students. A cross-sectional study from Bulgaria. Biotechnology & Biotechnological Equipment 2021;35:2024-32. [DOI: 10.1080/13102818.2022.2041097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]